Pharmacyte Biotech, Inc.盘中异动大幅拉升6.44%报2.15美元

自选股智能写手06-08

北京时间2024年06月08日03时07分，Pharmacyte Biotech, Inc.（PMCB.us）股票出现波动，股价快速拉升6.44%。截至发稿，该股报2.15美元/股，成交量3.3255万股，换手率0.39%，振幅10.40%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-619537.00美元，每股收益-0.65美元，毛利0.00美元，市盈率-1.43倍。机构评级方面...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2441097098?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-06-08 03:07","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2441097098","market":"us","top_or_hot":-1,"title":"Pharmacyte  Biotech, Inc.盘中异动 大幅拉升6.44%报2.15美元","media":"自选股智能写手","content":"<div>\n<p>北京时间2024年06月08日03时07分，Pharmacyte  Biotech, Inc.（PMCB.us）股票出现波动，股价快速拉升6.44%。截至发稿，该股报2.15美元/股，成交量3.3255万股，换手率0.39%，振幅10.40%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-619537.00美元，每股收益-0.65美元，毛利0.00美元，市盈率-1.43倍。机构评级方面...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240608030707aef4161a&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pharmacyte  Biotech, Inc.盘中异动 大幅拉升6.44%报2.15美元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPharmacyte  Biotech, Inc.盘中异动 大幅拉升6.44%报2.15美元\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-06-08 03:07 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240608030707aef4161a&s=b><strong>自选股智能写手</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间2024年06月08日03时07分，Pharmacyte  Biotech, Inc.（PMCB.us）股票出现波动，股价快速拉升6.44%。截至发稿，该股报2.15美元/股，成交量3.3255万股，换手率0.39%，振幅10.40%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-619537.00美元，每股收益-0.65美元，毛利0.00美元，市盈率-1.43倍。机构评级方面...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240608030707aef4161a&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"PMCB","symbol_name":"PharmaCyte Biotech, Inc.","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240608030707aef4161a&s=b","article_id":"2441097098","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240608030707aef4161a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2441097098","pubTimestamp":1717787227,"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"北京时间2024年06月08日03时07分，Pharmacyte  Biotech, Inc.股票出现波动，股价快速拉升6.44%。Pharmacyte  Biotech, Inc.股票所在的生物技术行业中，整体跌幅为0.08%。其相关个股中，Psyence Biomedical Ltd C/Wts 25/01/2029、Biocardia Inc C/Wts 06/08/2024、Cingulate Inc C/Wts 10/12/2026 涨幅较大，Biocardia, Inc.、Scinai Immunotherapeutics Ltd、Virax Biolabs Group Limited较为活跃，换手率分别为356.74%、116.51%、82.28%，振幅较大的相关个股有Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Psyence Biomedical Ltd C/Wts 25/01/2029、Ocean Biomedical Inc C/Wts 14/02/2028 ，振幅分别为178.69%、99.48%、65.15%。Pharmacyte  Biotech, Inc.公司简介：PharmaCyte Biotech Inc是一家临床阶段的生物技术公司。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"PMCB":"PharmaCyte Biotech, Inc.","BK4139":"生物科技"},"translate_title":"Pharmacyte Biotech, Inc. rose 6.44% to $2.15 in intraday changes","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"PMCB":0.9},"content_text":"北京时间2024年06月08日03时07分，Pharmacyte  Biotech, Inc.（PMCB.us）股票出现波动，股价快速拉升6.44%。截至发稿，该股报2.15美元/股，成交量3.3255万股，换手率0.39%，振幅10.40%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-619537.00美元，每股收益-0.65美元，毛利0.00美元，市盈率-1.43倍。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。Pharmacyte  Biotech, Inc.股票所在的生物技术行业中，整体跌幅为0.08%。其相关个股中，Psyence Biomedical Ltd C/Wts 25/01/2029(To Pur Com)、Biocardia Inc C/Wts 06/08/2024(To Pur Com)、Cingulate Inc C/Wts 10/12/2026 (To Pur Com)涨幅较大，Biocardia, Inc.、Scinai Immunotherapeutics Ltd、Virax Biolabs Group Limited较为活跃，换手率分别为356.74%、116.51%、82.28%，振幅较大的相关个股有Cero Therapeutics Holdings Inc C/Wts 13/02/2029 (To Pur Com)、Psyence Biomedical Ltd C/Wts 25/01/2029(To Pur Com)、Ocean Biomedical Inc C/Wts 14/02/2028 (To Pur Com)，振幅分别为178.69%、99.48%、65.15%。Pharmacyte  Biotech, Inc.公司简介：PharmaCyte Biotech Inc是一家临床阶段的生物技术公司。该公司专注于开发和准备商业化基于专有的纤维素活细胞封装技术(cell -in-a- box)的癌症和糖尿病细胞疗法。Cell-in-a-Box技术的目的是作为一个平台，在这个平台上包括不能手术的胰腺癌和糖尿病在内的几种癌症的治疗方法将被开发出来。该公司正在开发针对胰腺和其他实体癌肿瘤的治疗方法，包括将活细胞封装在体内，以便在癌症源头处输送抗癌药物。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2441097098"}

Pharmacyte Biotech, Inc.盘中异动 大幅拉升6.44%报2.15美元

精彩评论

Pharmacyte Biotech, Inc.盘中异动大幅拉升6.44%报2.15美元